Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)- Insider Own44.31% Shs Outstand43.12M Perf Week-16.01%
Market Cap574.79M Forward P/E- EPS next Y-4.12 Insider Trans12.11% Shs Float24.01M Perf Month-30.54%
Income- PEG- EPS next Q-0.74 Inst Own38.52% Short Float8.09% Perf Quarter-50.92%
Sales- P/S- EPS this Y96.08% Inst Trans- Short Ratio5.05 Perf Half Y-
Book/sh8.37 P/B1.59 EPS next Y-17.45% ROA- Short Interest1.94M Perf Year-
Cash/sh8.58 P/C1.55 EPS next 5Y- ROE- 52W Range12.26 - 35.06 Perf YTD-55.57%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-61.98% Beta-
Dividend TTM- Quick Ratio17.17 Sales past 5Y-37.90% Gross Margin- 52W Low8.73% ATR (14)1.52
Dividend Ex-Date- Current Ratio17.17 EPS Y/Y TTM- Oper. Margin- RSI (14)34.50 Volatility9.92% 10.57%
Employees96 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price42.75
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q- Payout- Rel Volume0.50 Prev Close13.70
Sales Surprise- EPS Surprise-33.33% Sales Q/Q- EarningsMay 14 AMC Avg Volume384.81K Price13.33
SMA20-11.07% SMA50-34.65% SMA200-41.80% Trades Volume192,931 Change-2.70%
Date Action Analyst Rating Change Price Target Change
Mar-04-24Initiated Wells Fargo Overweight $44
Mar-04-24Initiated Morgan Stanley Overweight $40
Mar-04-24Initiated Leerink Partners Outperform $48
Mar-04-24Initiated JP Morgan Overweight $39
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 05:48 PM
Northpond Ventures III GP, LLCFormer 10% OwnerFeb 12 '24Buy22.00450,0009,900,000450,000Feb 12 05:51 PM
Bain Capital Life Sciences Inv10% OwnerFeb 12 '24Buy22.00450,0009,900,0003,163,868Feb 14 05:26 PM
Vida Ventures, LLC10% OwnerFeb 12 '24Buy22.00253,1365,568,992252,553Feb 14 07:04 PM